Home/Filings/4/0001209191-17-003940
4//SEC Filing

ARATANA THERAPEUTICS, INC. 4

Accession 0001209191-17-003940

CIK 0001509190operating

Filed

Jan 16, 7:00 PM ET

Accepted

Jan 17, 6:10 PM ET

Size

8.4 KB

Accession

0001209191-17-003940

Insider Transaction Report

Form 4
Period: 2017-01-13
St Peter Steven
DirectorPRESIDENT AND CEO
Transactions
  • Award

    Stock Option (Right to Buy)

    2017-01-13+185,000185,000 total
    Exercise: $8.02Exp: 2027-01-12Common Stock (185,000 underlying)
  • Award

    Common Stock

    2017-01-13+139,900682,693 total
Holdings
  • Common Stock

    (indirect: By LLC)
    86,997
Footnotes (2)
  • [F1]Held in the name of Vie Venture LLC, a Delaware limited liability company ("Vie Venture"). The Reporting Person has sole voting and dispositive power over the shares held by Vie Venture, but disclaims beneficial ownership of the shares held thereby except to the extent of his pecuniary interest therein.
  • [F2]Vests as to 25% of the total number of shares (rounded down to the nearest whole share) on January 29, 2018 and as to an additional 1/48th of the total number of shares (rounded down to the nearest whole share) on the same day of each of the 36 successive calendar months thereafter, such that the stock option shall be vested as to all shares on January 29, 2021, subject to continued service with the Issuer through the applicable vesting dates.

Issuer

ARATANA THERAPEUTICS, INC.

CIK 0001509190

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001509190

Filing Metadata

Form type
4
Filed
Jan 16, 7:00 PM ET
Accepted
Jan 17, 6:10 PM ET
Size
8.4 KB